Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers. It also provides health plans through WholeHealth Living program; and health services, such as chiropractic care, acupuncture, physical therapy, occupational therapy, speech therapy, and others.
Read More…
Industry, Sector and Symbol
Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryHealth Care Services
SectorMedical
Phone800-869-5311
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$606.30 million
Profitability
Miscellaneous
Employees500
Next Earnings Date11/4/2019 (Estimated)
OptionableOptionable
Tivity Health (NASDAQ:TVTY) Frequently Asked Questions
What is Tivity Health's stock symbol?
Tivity Health trades on the NASDAQ under the ticker symbol "TVTY."
How were Tivity Health's earnings last quarter?
Tivity Health Inc (NASDAQ:TVTY) issued its quarterly earnings results on Wednesday, August, 7th. The company reported $0.64 EPS for the quarter, missing the Zacks' consensus estimate of $0.66 by $0.02. The company earned $340.40 million during the quarter, compared to the consensus estimate of $340.73 million. Tivity Health had a return on equity of 24.83% and a net margin of 8.88%. The firm's revenue for the quarter was up 124.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.53 EPS. View Tivity Health's Earnings History.
When is Tivity Health's next earnings date?
What guidance has Tivity Health issued on next quarter's earnings?
Tivity Health issued an update on its FY 2019 earnings guidance on Wednesday, August, 7th. The company provided earnings per share (EPS) guidance of $2.14-2.32 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.35. The company issued revenue guidance of $1.127-1.142 billion, compared to the consensus revenue estimate of $1.16 billion.
What price target have analysts set for TVTY?
8 brokers have issued twelve-month target prices for Tivity Health's shares. Their forecasts range from $25.00 to $45.00. On average, they expect Tivity Health's share price to reach $33.00 in the next year. This suggests a possible upside of 74.9% from the stock's current price. View Analyst Price Targets for Tivity Health.
What is the consensus analysts' recommendation for Tivity Health?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tivity Health in the last year. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Tivity Health.
What are Wall Street analysts saying about Tivity Health stock?
Here are some recent quotes from research analysts about Tivity Health stock:
- 1. According to Zacks Investment Research, "Tivity Health, Inc. provides health management services. The company offers services which include chiropractic services, physical therapy, occupational therapy, speech therapy, acupuncture, massage and complementary and alternative medicine services. Its network comprises SilverSneakers(R), Prime(R) Fitness and WholeHealth Living (TM). Tivity Health, Inc., formerly known as Healthways, Inc., is based in Franklin, Tennessee. " (8/9/2019)
- 2. Cantor Fitzgerald analysts commented, ". We reiterate our Overweight rating on TVTY shares and maintain our $40 price target. Last month, Tivity completed the acquisition of Nutrisystem, a leading provider of weight management products and services. While the acquisition has been met with investor skepticism, we believe the combination is logical and provides an attractive growth opportunity for TVTY. To better understand the value proposition of the merger, our note includes a detailed overview on the nutrition/weight management industry. Our findings support our view that the combined company should be able to generate significant revenue synergies." (4/22/2019)
Has Tivity Health been receiving favorable news coverage?
News coverage about TVTY stock has been trending positive recently, InfoTrie Sentiment reports. InfoTrie rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Tivity Health earned a daily sentiment score of 2.5 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 6.0 out of 10, meaning that recent media coverage is somewhat likely to have an effect on the stock's share price in the near future. View News Stories for Tivity Health.
Who are some of Tivity Health's key competitors?
What other stocks do shareholders of Tivity Health own?
Who are Tivity Health's key executives?
Tivity Health's management team includes the folowing people:
- Mr. Donato J. Tramuto, CEO & Director (Age 62)
- Mr. Adam C. Holland, Chief Financial Officer (Age 40)
- Ms. Mary S. Flipse, Chief Legal & Admin. Officer (Age 52)
- Ms. Dawn M. Zier, Pres, COO & Director (Age 54)
- Mr. Ryan Wagers, Chief Accounting Officer & Controller (Age 41)
Who are Tivity Health's major shareholders?
Tivity Health's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (15.35%), Vanguard Group Inc. (12.80%), HG Vora Capital Management LLC (9.93%), Morgan Stanley (5.79%), Bank of America Corp DE (3.46%) and Wells Fargo & Company MN (2.75%). Company insiders that own Tivity Health stock include Bradley S Karro, Conan Laughlin, Donato Tramuto, Glenn Hargreaves, Mary Flipse and Sara Finley. View Institutional Ownership Trends for Tivity Health.
Which major investors are selling Tivity Health stock?
TVTY stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Vanguard Group Inc., Man Group plc, Wells Fargo & Company MN, Renaissance Technologies LLC, Freestone Capital Holdings LLC, Invesco Ltd. and JPMorgan Chase & Co.. View Insider Buying and Selling for Tivity Health.
Which major investors are buying Tivity Health stock?
TVTY stock was purchased by a variety of institutional investors in the last quarter, including HG Vora Capital Management LLC, Morgan Stanley, Bank of America Corp DE, BlackRock Inc., State of New Jersey Common Pension Fund D, Nuveen Asset Management LLC, Parametric Portfolio Associates LLC and Barrow Hanley Mewhinney & Strauss LLC. Company insiders that have bought Tivity Health stock in the last two years include Bradley S Karro and Sara Finley. View Insider Buying and Selling for Tivity Health.
How do I buy shares of Tivity Health?
Shares of TVTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Tivity Health's stock price today?
One share of TVTY stock can currently be purchased for approximately $18.87.
How big of a company is Tivity Health?
Tivity Health has a market capitalization of $902.55 million and generates $606.30 million in revenue each year. The company earns $98.80 million in net income (profit) each year or $2.34 on an earnings per share basis. Tivity Health employs 500 workers across the globe.View Additional Information About Tivity Health.
What is Tivity Health's official website?
How can I contact Tivity Health?
Tivity Health's mailing address is 701 Cool Springs Boulevard, Franklin TN, 37067. The company can be reached via phone at 800-869-5311 or via email at [email protected]
MarketBeat Community Rating for Tivity Health (NASDAQ TVTY)
MarketBeat's community ratings are surveys of what our community members think about Tivity Health and other stocks. Vote "Outperform" if you believe TVTY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TVTY will underperform the S&P 500 over the long term. You may vote once every thirty days.
